These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 33218982)
21. [Rapid hemoglobin A1c determination (a new possibility in diabetes care)]. Jermendy G; Nádas J; Farkas K Orv Hetil; 1999 May; 140(22):1251-4. PubMed ID: 10377737 [TBL] [Abstract][Full Text] [Related]
22. Impact of Distress Reduction on Behavioral Correlates and A1C in African American Women with Uncontrolled Type 2 Diabetes: Results from EMPOWER. Cummings DM; Lutes LD; Littlewood K; Solar C; Hambidge B; Gatlin P Ethn Dis; 2017; 27(2):155-160. PubMed ID: 28439186 [TBL] [Abstract][Full Text] [Related]
23. Glycated Hemoglobin and Blood Pressure Levels in Adults With Type 2 Diabetes: How Many Patients Are on Target? Bergonsi de Farias C; Coelli S; Satler F; Brondani L; Zelmanovitz T; Silveiro SP Can J Diabetes; 2021 Jun; 45(4):334-340. PubMed ID: 33277195 [TBL] [Abstract][Full Text] [Related]
24. Hemoglobin A1c testing in an emergency department. Magee MF; Nassar C J Diabetes Sci Technol; 2011 Nov; 5(6):1437-43. PubMed ID: 22226261 [TBL] [Abstract][Full Text] [Related]
25. Haemoglobin A1c goal attainment in relation to dose in patients with diabetes mellitus taking metformin: a nested, case-control study. Penning-van Beest FJ; Wolffenbuttel BH; Herings RM Clin Drug Investig; 2008; 28(8):487-93. PubMed ID: 18598094 [TBL] [Abstract][Full Text] [Related]
26. Impact of Timely Treatment Intensification on Glycemic Goal Achievement in Patients With Type 2 Diabetes Failing Metformin Monotherapy. Mahabaleshwarkar R; Templin M; Gohs F; Mulder H; DeSantis A; Ejzykowicz F; Rajpathak S; Wilkins N Diabetes Educ; 2017 Oct; 43(5):495-505. PubMed ID: 28828933 [TBL] [Abstract][Full Text] [Related]
27. Diabetes Mellitus Treatment Deintensification: When Well-Controlled Diabetes Mellitus Becomes Overcontrolled. Raghavan S; Matlock D Circ Cardiovasc Qual Outcomes; 2017 Apr; 10(4):. PubMed ID: 28416532 [No Abstract] [Full Text] [Related]
28. [Guidelines "Diabetes mellitus in the elderly"]. Zeyfang A; Braun A MMW Fortschr Med; 2009 May; 151(20):33-5, 37. PubMed ID: 19728661 [No Abstract] [Full Text] [Related]
29. Lifestyle, Glycosylated Hemoglobin A1c, and Survival Among Patients With Stable Ischemic Heart Disease and Diabetes. Mancini GBJ; Maron DJ; Hartigan PM; Spertus JA; Kostuk WJ; Berman DS; Teo KK; Weintraub WS; Boden WE; J Am Coll Cardiol; 2019 Apr; 73(16):2049-2058. PubMed ID: 31023428 [TBL] [Abstract][Full Text] [Related]
30. Road maps to achieve glycemic control in type 2 diabetes mellitus: ACE/AACE Diabetes Road Map Task Force. Jellinger PS; Davidson JA; Blonde L; Einhorn D; Grunberger G; Handelsman Y; Hellman R; Lebovitz H; Levy P; Roberts VL; Endocr Pract; 2007; 13(3):260-8. PubMed ID: 17599857 [No Abstract] [Full Text] [Related]
31. Escaping the Hemoglobin A1c-Centric World in Evaluating Diabetes Mellitus Interventions. Vigersky RA J Diabetes Sci Technol; 2015 Feb; 9(5):1148-51. PubMed ID: 25697718 [TBL] [Abstract][Full Text] [Related]
32. Treat-to-target HbA Gagliardino JJ; Elgart J; Forti L; Guaita MS; Chantelot JM Diabetes Metab Res Rev; 2019 Sep; 35(6):e3166. PubMed ID: 30963685 [TBL] [Abstract][Full Text] [Related]
33. Comment on: Polonsky et al. Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes: results from the structured testing program study. Diabetes Care 2011;34:262-267. Stephens JW; Carman JE; Brooks CJ; Lyons RA; Ford DV; Price DE; Bain SC Diabetes Care; 2011 May; 34(5):e57; author reply e58. PubMed ID: 21525497 [No Abstract] [Full Text] [Related]
34. Management of Daily Glycemic Fluctuations in Patients With Type 2 Diabetes. Kushner PR J Fam Pract; 2016 Nov; 65(11 Suppl):. PubMed ID: 28087879 [TBL] [Abstract][Full Text] [Related]
35. Hemoglobin A1C testing frequency among patients with type 2 diabetes within a US payer system: a retrospective observational study. Weiss T; Edwards A; Lautsch D; Rajpathak S; Snow K Curr Med Res Opin; 2021 Nov; 37(11):1859-1866. PubMed ID: 34402701 [TBL] [Abstract][Full Text] [Related]
36. Improved Glycemic Control Outcomes Regardless of Mental Health Disorders in a Pharmacist-Endocrinologist Diabetes Intense Medical Management (DIMM) "Tune Up" Clinic. Morello CM; Nguyen T; Tao L; Hirsch JD Ann Pharmacother; 2020 Sep; 54(9):858-865. PubMed ID: 32100551 [No Abstract] [Full Text] [Related]
37. Use of integrated care delivery to improve the quality of diabetes management among African Americans. Bray P; Cummings DM; Thompson DK N C Med J; 2011; 72(5):390-2. PubMed ID: 22416520 [TBL] [Abstract][Full Text] [Related]
38. Pharmacist-physician collaborative care model for patients with uncontrolled type 2 diabetes in Brazil: results from a randomized controlled trial. Aguiar PM; da Silva CHP; Chiann C; Dórea EL; Lyra DP; Storpirtis S J Eval Clin Pract; 2018 Feb; 24(1):22-30. PubMed ID: 27452158 [TBL] [Abstract][Full Text] [Related]
39. Clinical impact of initiating insulin glargine therapy with disposable pen versus vial in patients with type 2 diabetes mellitus in a managed care setting. Davis SN; Wei W; Garg S Endocr Pract; 2011; 17(6):845-52. PubMed ID: 21550952 [TBL] [Abstract][Full Text] [Related]
40. DOES CLINICAL INERTIA VARY BY PERSONALIZED A1C GOAL? A STUDY OF PREDICTORS AND PREVALENCE OF CLINICAL INERTIA IN A U.S. MANAGED-CARE SETTING. Lin J; Zhou S; Wei W; Pan C; Lingohr-Smith M; Levin P Endocr Pract; 2016 Feb; 22(2):151-61. PubMed ID: 26492540 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]